17:0-20:3 PS-d 5 (1-Heptadecanoyl-2-eicosatrienoyl-sn-glycero(d 5 )-3-phospho- L-serine (sodium)) is deuterium labeled 17:0-20:3 PS [1].
References:
[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216.
References:
[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216.
















